» Articles » PMID: 32133797

Roles of Pattern Recognition Receptors in Diabetic Nephropathy

Overview
Date 2020 Mar 6
PMID 32133797
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic nephropathy (DN) is currently the most common complication of diabetes. It is considered to be one of the leading causes of end-stage renal disease (ESRD) and affects many diabetic patients. The pathogenesis of DN is extremely complex and has not yet been clarified; however, in recent years, increasing evidence has shown the important role of innate immunity in DN pathogenesis. Pattern recognition receptors (PRRs) are important components of the innate immune system and have a significant impact on the occurrence and development of DN. In this review, we classify PRRs into secretory, endocytic, and signal transduction PRRs according to the relationship between the PRRs and subcellular compartments. PRRs can recognize related pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), thus triggering a series of inflammatory responses, promoting renal fibrosis, and finally causing renal impairment. In this review, we describe the proposed role of each type of PRRs in the development and progression of DN.

Citing Articles

Advancements and challenges in brain cancer therapeutics.

Bai F, Deng Y, Li L, Lv M, Razzokov J, Xu Q Exploration (Beijing). 2024; 4(6):20230177.

PMID: 39713205 PMC: 11655316. DOI: 10.1002/EXP.20230177.


HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4.

Yu J, Da J, Yu F, Yuan J, Zha Y J Endocrinol Invest. 2024; 47(4):1015-1027.

PMID: 38409569 DOI: 10.1007/s40618-023-02292-0.


.

Jiang P, Yao C, Guo D Acta Pharm Sin B. 2024; 14(1):38-66.

PMID: 38239236 PMC: 10793104. DOI: 10.1016/j.apsb.2023.11.006.


Male Akita mice develop signs of bladder underactivity independent of NLRP3 as a result of a decrease in neurotransmitter release from efferent neurons.

Hughes Jr F, Allkanjari A, Odom M, Mulcrone J, Jin H, Purves J Am J Physiol Renal Physiol. 2023; 325(1):F61-F72.

PMID: 37167271 PMC: 10292983. DOI: 10.1152/ajprenal.00284.2022.


Prospective Analysis of B Lymphocyte Subtypes, before and after Initiation of Dialysis, in Patients with End-Stage Renal Disease.

Daikidou D, Lioulios G, Sampani E, Xochelli A, Nikolaidou V, Moysidou E Life (Basel). 2023; 13(4).

PMID: 37109388 PMC: 10146774. DOI: 10.3390/life13040860.


References
1.
Gysler S, Mulla M, Guerra M, Brosens J, Salmon J, Chamley L . Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. Mol Hum Reprod. 2016; 22(7):465-74. PMC: 4941806. DOI: 10.1093/molehr/gaw027. View

2.
Thakur V, Nargis S, Gonzalez M, Pradhan S, Terreros D, Chattopadhyay M . Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease. Nephron. 2017; 137(2):137-147. DOI: 10.1159/000477820. View

3.
Lu L, Peng W, Wang W, Wang L, Chen Q, Shen W . Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats. J Zhejiang Univ Sci B. 2011; 12(8):652-9. PMC: 3150719. DOI: 10.1631/jzus.B1101004. View

4.
Ye Y, Chen Q, Li J, Jin L, Zheng J, Li X . CXCL16 deficiency attenuates diabetic nephropathy through decreasing oxidative stress and inflammation. Biochem Biophys Res Commun. 2017; 491(3):848-854. DOI: 10.1016/j.bbrc.2017.05.013. View

5.
Zhao L, Wu F, Jin L, Lu T, Yang L, Pan X . Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus. PLoS One. 2014; 9(1):e87786. PMC: 3906379. DOI: 10.1371/journal.pone.0087786. View